Market revenue in 2022 | USD 4,028.6 million |
Market revenue in 2030 | USD 6,724.9 million |
Growth rate | 6.6% (CAGR from 2022 to 2030) |
Largest segment | Osteoarthritis |
Fastest growing segment | Ophthalmic |
Historical data covered | 2017 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux |
Key market players worldwide | Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hyaluronic acid market will help companies and investors design strategic landscapes.
Osteoarthritis was the largest segment with a revenue share of 42.31% in 2022. Horizon Databook has segmented the North America hyaluronic acid market based on dermal fillers, osteoarthritis, ophthalmic, vesicoureteral reflux covering the revenue growth of each sub-segment from 2017 to 2030.
Viscosupplements for the treatment of osteoarthritis and soft tissue dermal fillers are witnessing high demand in North America. This can be attributed to greater preference for minimally invasive and shortduration treatment regimens in the U.S. & Canada.
According to morbidity and mortality report published by the CDC, 58.9% of the U.S. population suffers from some form of arthritis. Thus, increasing prevalence of osteoarthritis and growing preference for minimally invasive procedures are among factors fueling market growth in North America.
Hyaluronic acid-based dermal filler procedures are gaining popularity in North America. According to the ISAPS, 807,870 million hyaluronic acid procedures were performed in the U.S. in 2020. Hyaluronic acid dermal fillers are utilized for the correction of aging signs, skin contouring, reduction of depressions, and lip & cheek augmentation.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America hyaluronic acid market , including forecasts for subscribers. This continent databook contains high-level insights into North America hyaluronic acid market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account